[Federal Register Volume 84, Number 100 (Thursday, May 23, 2019)]
[Notices]
[Pages 23812-23813]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-10760]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2018-0230]


Draft Approaches for Addressing Training and Experience 
Requirements for Radiopharmaceuticals Requiring a Written Directive

AGENCY: Nuclear Regulatory Commission.

ACTION: Request for comment; extension of comment period.

-----------------------------------------------------------------------

SUMMARY: On May 2, 2019, the U.S. Nuclear Regulatory Commission (NRC) 
requested comments on draft approaches regarding the training and 
experience (T&E) requirements for radiopharmaceuticals requiring a 
written directive. The public comment period was originally scheduled 
to close on June 3, 2019. The NRC is extending the comment period to 
July 3, 2019, to allow more time for stakeholders and members of the 
public to submit their comments.

DATES: The due date of comments requested in the notice published on 
May 2, 2019 (84 FR 18874) is extended. Comments should be submitted no 
later than July 3, 2019. Comments received after this date will be 
considered if it is practical to do so, but the NRC is only able to 
ensure consideration for comments received on or before this date.

ADDRESSES: You may submit comments by any of the following methods:
     Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC-2018-0230. Address 
questions about NRC docket IDs in regulations.gov to Jennifer Borges; 
telephone: 301-287-9127; email: [email protected]. For technical 
questions, contact the individual listed in the FOR FURTHER INFORMATION 
CONTACT section of this document.
     Mail comments to: Office of Administration, Mail Stop: 
TWFN-7-A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555-
0001, ATTN: Program Management, Announcements and Editing Staff.
    For additional direction on obtaining information and submitting 
comments, see ``Obtaining Information and Submitting Comments'' in the 
SUPPLEMENTARY INFORMATION section of this document.

FOR FURTHER INFORMATION CONTACT: Sarah Lopas, Office of Nuclear 
Material Safety and Safeguards, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-6360, email: 
[email protected].

SUPPLEMENTARY INFORMATION: 

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2018-0230 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal Rulemaking Website: Go to http://www.regulations.gov and search for Docket ID NRC-2018-0230.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at http://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, 301-415-4737, or 
by email to [email protected]. The ADAMS accession number for each 
document referenced is provided the first time that it is mentioned in 
the SUPPLEMENTARY INFORMATION section.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

B. Submitting Comments

    Please include Docket ID NRC-2018-0230 in your comment submission. 
The

[[Page 23813]]

NRC cautions you not to include identifying or contact information in 
comment submissions that you do not want to be publicly disclosed in 
your comment submission. All comment submissions are posted at http://www.regulations.gov and entered into ADAMS. Comment submissions are not 
routinely edited to remove identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment into ADAMS.

II. Discussion

    On May 2, 2019, the NRC published a notice in the Federal Register 
(84 FR 18874) requesting comments on draft approaches the staff 
developed regarding the T&E requirements for radiopharmaceuticals 
requiring a written directive. The public comment period was originally 
scheduled to close on June 3, 2019. By letter dated May 13, 2019 (ADAMS 
Accession No. ML19136A236), the American College of Radiology, the 
American Society for Radiation Oncology, and the Society of Nuclear 
Medicine and Molecular Imaging jointly requested a 30-day extension to 
the public comment period. United Pharmacy Partners, Inc. also 
submitted a request for extension by letter dated May 14, 2019 (ADAMS 
Accession No. ML19136A238). Additional requests for an extension to the 
public comment period were also heard during a May 14, 2019, public 
comment meeting. The NRC is granting this request and will extend the 
public comment period until July 3, 2019, to allow more time for 
medical and regulatory stakeholders and members of the public to submit 
their comments.

    Dated at Rockville, Maryland, this 17th day of May 2019.

    For the Nuclear Regulatory Commission.
Andrea L. Kock,
Director, Division of Materials Safety, Security, State, and Tribal 
Programs, Office of Nuclear Material Safety and Safeguards.
[FR Doc. 2019-10760 Filed 5-22-19; 8:45 am]
 BILLING CODE 7590-01-P